Insider · CIK 0001671311

Jarrett Jennifer

Reports to the SEC for 10 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001671311

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-25	DMRADamora Therapeutics, Inc.P Purchase	Director, Director, President and CEO	PPurchase	+12.5K sh	$20.23	+$253K	512,500
2026-06-17	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+51K sh	—	—	51,000
2026-06-12	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+39.6K sh	—	—	39,567
2026-03-30	DMRADamora Therapeutics, Inc.A Award	Director, Director, President and CEO	AAward	+500K sh	—	—	500,000
2026-03-30	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Director, President and CEO	AAward	+1.5M sh	—	—	1,500,000
2026-02-04	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+24K sh	—	—	114,000
2026-01-23	RCUSArcus Biosciences, Inc.A Award	Chief Operating Officer	AAward	+31K sh	—	—	224,024
2026-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+126K sh	—	—	126,000
2025-12-17	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−9,983 sh	$22.16	−$221K	193,024
2025-12-16	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−11.2K sh	$21.88	−$246K	203,007
2025-11-07	RCUSArcus Biosciences, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+50.3K sh	$1.23	+$61.7K	264,523
2025-11-07	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−50.3K sh	$18.97	−$954K	214,232
2025-11-07	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−50.3K sh	$1.23	−$61.7K	80,583
2025-10-08	RCUSArcus Biosciences, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+37.8K sh	$1.23	+$46.4K	252,024
2025-10-08	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−37.8K sh	$15.05	−$569K	214,232
2025-10-08	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−37.8K sh	—	—	130,874
2025-10-06	RCUSArcus Biosciences, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+12.5K sh	$1.23	+$15.3K	226,732
2025-10-06	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−12.5K sh	$14.54	−$182K	214,232
2025-10-06	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−12.5K sh	—	—	168,666
2025-06-09	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.3K sh	—	—	27,268
2025-05-21	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+51K sh	—	—	51,000
2025-02-05	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+25K sh	—	—	90,000
2025-01-23	RCUSArcus Biosciences, Inc.A Award	Chief Operating Officer	AAward	+50K sh	—	—	213,369
2025-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+200K sh	—	—	200,000
2024-12-15	RCUSArcus Biosciences, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−27.5K sh	$16.08	−$442K	163,369
2024-12-09	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+117K sh	—	—	117,000
2024-09-15	RCUSArcus Biosciences, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−12.7K sh	$17.95	−$227K	190,394
2024-08-01	SGMTSagimet Biosciences Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+114K sh	—	—	113,895
2024-06-15	RCUSArcus Biosciences, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−12.7K sh	$16.97	−$215K	203,064
2024-03-27	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−11.6K sh	$17.55	−$203K	215,253
2024-03-18	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−12.2K sh	$17.84	−$217K	228,100
2024-03-18	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−1,296 sh	$18.62	−$24.1K	226,804
2024-02-27	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−34.1K sh	$20.11	−$685K	240,253
2024-02-26	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−24.6K sh	$20.07	−$493K	274,323
2024-02-07	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+17K sh	—	—	65,000
2024-01-23	RCUSArcus Biosciences, Inc.A Award	Chief Operating Officer	AAward	+40K sh	—	—	298,878
2024-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+162K sh	—	—	162,400
2023-12-22	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−21.5K sh	$17.76	−$382K	258,878
2023-12-19	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−11.5K sh	$18.09	−$208K	280,399
2023-12-18	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−11.3K sh	$17.74	−$200K	291,891
2023-09-22	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−21.4K sh	$19.99	−$427K	302,691
2023-09-18	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−12.5K sh	$20.40	−$255K	324,060
2023-07-28	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−45K sh	$20.25	−$911K	336,566
2023-06-22	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−12.4K sh	$19.12	−$238K	381,566
2023-06-16	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−12.6K sh	$19.35	−$243K	394,003
2023-05-18	ZURAZura Bio Ltd · Employee Share Option (Right to Buy)A Award	Director	AAward	+7,652 sh	—	—	7,652
2023-03-16	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−8,729 sh	$16.81	−$147K	406,217
2023-02-02	SNDXSyndax Pharmaceuticals IncA Award	Director	AAward	+16K sh	—	—	48,000
2023-01-27	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−1,600 sh	$23.52	−$37.6K	414,946
2023-01-26	RCUSArcus Biosciences, Inc.S Sale	Chief Operating Officer	SSale	−300 sh	$23.56	−$7,068	416,546

Recent filings

Accepted (ET)
Sep 284
Jarrett Jennifer0001193125-26-403355
SEC(opens sec.gov)
Jun 224
Jarrett Jennifer0001671311-26-000005
SEC(opens sec.gov)
Jun 154
Jarrett Jennifer0001104659-26-074050
SEC(opens sec.gov)
Apr 14
Jarrett Jennifer0001193125-26-138275
SEC(opens sec.gov)
Feb 64
Jarrett Jennifer0001193125-26-041412
SEC(opens sec.gov)
Jan 264
Jarrett Jennifer0001671311-26-000002
SEC(opens sec.gov)
Dec 184
Jarrett Jennifer0001671311-25-000009
SEC(opens sec.gov)
Nov 124
Jarrett Jennifer0001671311-25-000005
SEC(opens sec.gov)
Oct 84
Jarrett Jennifer0001671311-25-000003
SEC(opens sec.gov)
Jun 104
Jarrett Jennifer0001104659-25-058222
SEC(opens sec.gov)

Companies

Address

C/O DAMORA THERAPEUTICS, INC. 100 FIFTH AVENUE, SUITE 700

WALTHAM, MA, 02451